822 Participants Needed

Educational Support for Lung Cancer Screening

RM
Overseen ByRonald Myers, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ronald Myers
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

This clinical trial tests how well providing education improves screening for lung cancer in patients with a history of smoking. Screenings may help doctors find lung cancer sooner when it may be easier to treat. Education and counseling may be an effective method to help providers and patients learn about lung cancer screening. Providing education and decision counseling to providers and patients may increase lung cancer screening.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It focuses on education and counseling for lung cancer screening.

What data supports the effectiveness of the treatment Educational Support for Lung Cancer Screening?

Research shows that educating cancer patients helps them manage treatment side effects better, reduces stress and anxiety, and improves cooperation with treatment plans. Additionally, wellness education has been found to positively influence behavior and psychological status in lung cancer patients.12345

Is educational support for lung cancer screening safe for humans?

Educational support, such as wellness education and therapeutic education, is generally safe for humans. It helps patients understand and manage treatment side effects, though a lack of information can sometimes lead to adverse events.15678

How does the educational support treatment for lung cancer screening differ from other treatments?

The educational support treatment for lung cancer screening is unique because it focuses on providing patients with knowledge and skills to manage their condition, rather than directly treating the cancer itself. This approach helps patients understand their disease, cope with stress, and improve their cooperation with medical regimens, which can lead to better overall outcomes.125910

Eligibility Criteria

This trial is for adults aged 50-77 who currently smoke or quit within the last 15 years, with a significant smoking history. They must be able to communicate in English or Spanish and have an upcoming primary care visit. Excluded are those recently hospitalized, with dementia, prior lung cancer, or recent CT scans.

Inclusion Criteria

Practice Level: Practice using the main electronic medical record (EMR) of each system, in order to run appropriate patient recruitment reports
Practice Level: Primary care practice (family medicine, geriatrics, internal medicine) in one of the 4 participating health systems
Practice Level: Practice with at least 50% of practice providers (physicians and advanced care providers) consenting to participate
See 5 more

Exclusion Criteria

Patient Outreach: Prior history of lung cancer
I was hospitalized within the last 60 days.
Patient Outreach: Dementia diagnosis codes F03.90 or F03.91 in EHR
See 1 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Providers and patients undergo educational activities and counseling to improve lung cancer screening

4 months
Multiple sessions (online and in-person)

Follow-up

Participants are monitored for repeat annual lung cancer screenings and diagnostic follow-up

11-16 months

Long-term Follow-up

Participants are monitored for tobacco cessation services and lung cancer screening referrals

Up to 5 years

Treatment Details

Interventions

  • Counseling
  • Education
Trial Overview The study evaluates if education and counseling can increase lung cancer screening rates among smokers or recent quitters. It involves survey administration, electronic health record review, and educational activities aimed at both healthcare providers and patients.
Participant Groups
4Treatment groups
Experimental Treatment
Active Control
Group I: Group A (Providers): (survey, online educational activity)Experimental Treatment2 Interventions
Participants complete survey on study. Participants undergo online educational activity on study. Participants undergo distance learning on study.
Group II: Group A (Patients): (EHR, educational activity, counseling))Experimental Treatment3 Interventions
Patients undergo EHR review on study. Patients undergo educational activity on study. Patients also undergo SDM counseling once on study.
Group III: Group B (Patients): (survey)Active Control2 Interventions
Patients undergo EHR review on study and complete telephone survey throughout the trial.
Group IV: Group B (Providers): (survey)Active Control1 Intervention
Participants complete survey at baseline and end of study survey.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ronald Myers

Lead Sponsor

Trials
1
Recruited
820+

Thomas Jefferson University

Lead Sponsor

Trials
475
Recruited
189,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

Findings from Research

Patients with lung cancer who received education about treatment and rehabilitation during chemotherapy had significantly lower rates of severe treatment side effects (14.52% vs. 37.27%) compared to those who did not receive this information.
The intervention group also showed better outcomes in terms of daily protein intake (54.84% vs. 70.00% low intake), lower prevalence of depression (51.61% vs. 70.91%), and improved performance status (75.81% vs. 55.45%).
Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients.Tian, J., Jia, LN., Cheng, ZC.[2018]
Cancer patient education should go beyond just providing information; it must also include teaching coping skills and new strategies to manage the disease, which can lead to better treatment adherence and reduced anxiety.
Focusing on the different phases of cancer care can help identify essential educational content, and ongoing research is crucial for developing effective teaching methods and evaluating their impact on patient outcomes.
Information and education across the phases of cancer care.Adams, M.[2019]
Cancer patient education programs are crucial, especially for those undergoing active treatment, as they help manage treatment side effects and improve coping strategies.
Future improvements in these programs should focus on using appropriate measurement tools, ensuring adequate sample sizes, and incorporating psychological techniques to enhance patient support and potentially reduce healthcare costs.
Cancer patient education: reality and potential.Rimer, B., Keintz, MK., Glassman, B.[2019]

References

Relationships between patient knowledge and the severity of side effects, daily nutrient intake, psychological status, and performance status in lung cancer patients. [2018]
Information and education across the phases of cancer care. [2019]
Cancer patient education: reality and potential. [2019]
The nurse's role in nutritional management of radiotherapy patients. [2008]
Influence of wellness education on first-line icotinib hydrochloride patients with stage IV non-small cell lung cancer and their family caregivers. [2019]
Impact of an early education multimedia intervention in managing nutrition-related chemotherapy side effects: a pilot study. [2021]
[Potential clinical impact of therapeutic education in patients treated with anticancer drugs]. [2017]
Empowering individuals to self-manage chemotherapy side effects. [2022]
Cancer patient education: what, where, and by whom? [2007]
10.United Statespubmed.ncbi.nlm.nih.gov
Computed Tomography Scanning for Early Detection of Lung Cancer. [2019]